MARKET

CFMS

CFMS

ConforMIS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.100
+0.020
+1.85%
Pre Market: 1.100 0 0.00% 08:24 02/25 EST
OPEN
1.080
PREV CLOSE
1.080
HIGH
1.120
LOW
1.030
VOLUME
70.23K
TURNOVER
--
52 WEEK HIGH
1.490
52 WEEK LOW
0.5003
MARKET CAP
194.15M
P/E (TTM)
-3.2343
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
CCIV, NLS among premarket losers
Churchill Capital (CCIV) -35% after $11.75B transaction with Lucid Motors.Mercurity Fintech (MFH) -20%.Pintec Technology (PT) -20%.Xcel Brands (XELB) -17%.SOS (SOS) -18%.PAVmed (PAVM) -18% on capital raise.Taoping (TAOP) -15% after $7.75M private placement...
Seekingalpha · 2d ago
VUZI, PBR, CLSN and WATT among midday movers
Gainers: ReTo Eco-Solutions (RETO) +93%.Celsion (CLSN) +62%.Rodgers Silicon Valley Acquisition (RSVA) +49%.Taoping (TAOP) +44%.RealNetworks (RNWK) +32%.Cooper Tire & Rubber (CTB) +30%.MICT (MICT) +26%.Conformis (CFMS) +26%.ATIF Holdings (ATIF) +25%.Vuzix (...
Seekingalpha · 2d ago
Shares rise as Conformis wins FDA 510(k) approval for knee replacement systems
The FDA has granted Conformis (CFMS) 510(k) approval for its ITotal Identity Cruciate Retaining Knee Replacement System and ITotal Identity Posterior Stabilizing Knee Replacement system.The 510(k) paperwork was received by
Seekingalpha · 2d ago
GME, CCIV, PBCT and VUZI among premarket gainers
ReTo Eco-Solutions (RETO) +132%.ATIF Holdings Limited (ATIF) +70% on establishing SPAC department to plan establishment of SPAC.Xcel Brands  (XELB) +52%.Celsion Corporation (CLSN) +48% after receiving FDA fast track designation for GEN-1.Can-Fite BioPharma
Seekingalpha · 3d ago
Thinking about buying stock in Celsion Corp, Can Fite Biopharma, ConforMIS Inc, Citius Pharmaceuticals, or Vuzix Corp?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSN, CANF, CFMS, CTXR, and VUZI.
PR Newswire - PRF · 3d ago
Shoulder Implants Market Provides an In-Depth Insight of Sales, Revenue, Analysis of Growth Factors and Upcoming Trends, Opportunities by Types and Application to 2026 Says Industry Research Biz
The Express Wire · 3d ago
BRIEF-Conformis Says On Feb 17, Received A Letter From Nasdaq Notifying Co Has Regained Compliance
reuters.com · 6d ago
ConforMIS (CFMS) Receives a Buy from Oppenheimer
Oppenheimer analyst Steven Lichtman maintained a Buy rating on ConforMIS (CFMS) today and set a price target of $3.00. The company's shares closed last
SmarterAnalyst · 6d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CFMS. Analyze the recent business situations of ConforMIS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CFMS stock price target is 2.333 with a high estimate of 3.000 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 124
Institutional Holdings: 19.74M
% Owned: 11.19%
Shares Outstanding: 176.50M
TypeInstitutionsShares
Increased
13
1.23M
New
11
-7.33M
Decreased
11
874.81K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.93%
Healthcare Equipment & Supplies
+0.66%
Key Executives
Chairman/Independent Director
Kenneth Fallon
President/Chief Executive Officer/Director
Mark Augusti
Chief Financial Officer/Treasurer
Robert Howe
Senior Vice President
Gary Maingot
Secretary
J. Brent Alldredge
Director
Carrie Bienkowski
Independent Director
Philip Johnston
Independent Director
Bradley Langdale
Independent Director
Richard Meelia
Independent Director
Michael Milligan
  • Dividends
  • Splits
  • Insider Activity
No Data
About CFMS
ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Webull offers kinds of ConforMIS Inc stock information, including NASDAQ:CFMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CFMS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CFMS stock methods without spending real money on the virtual paper trading platform.